Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level

Abstract Background Inadequate myocardial glucose metabolism suppression (GMS) can hamper interpretation of cardiac [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET/CT). Use of β-hydroxybutyrate (BHB) measurement before [18F]FDG injection has been proposed for predicting adequate GMS....

詳細記述

書誌詳細

出版年:	EJNMMI Research
主要な著者:	Suvi Hartikainen, Ville Vepsäläinen, Tiina Laitinen, Marja Hedman, Tomi Laitinen, Tuomo Tompuri
フォーマット:	論文
言語:	英語
出版事項:	SpringerOpen 2024-10-01
主題:	Myocardial inflammation Beta-hydroxybutyrate BHB FDG-PET Glucose metabolism Myocardium
オンライン･アクセス:	https://doi.org/10.1186/s13550-024-01153-y